Travere Therapeutics
TVTX
Travere Therapeutics (TVTX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Evercore ISI Group | Maintained | Outperform | $78.00 from $68.00 | Aug 10, 2026 |
| Wedbush | Maintained | Outperform | $75.00 from $61.00 | Aug 6, 2026 |
| Canaccord Genuity | Maintained | Buy | $70.00 from $62.00 | Aug 6, 2026 |
| Guggenheim | Maintained | Buy | $75.00 from $65.00 | Aug 5, 2026 |
| Evercore ISI Group | Maintained | Outperform | $68.00 from $60.00 | Aug 5, 2026 |
| Citigroup | Maintained | Buy | $85.00 from $70.00 | Aug 5, 2026 |
| TD Cowen | Maintained | Buy | $75.00 from $60.00 | Aug 5, 2026 |
| Canaccord Genuity | Maintained | Buy | $62.00 from $56.00 | Jul 30, 2026 |
| Guggenheim | Maintained | Buy | $65.00 from $56.00 | Jun 25, 2026 |
| Wedbush | Maintained | Outperform | $61.00 from $55.00 | Jun 22, 2026 |
| Evercore ISI Group | Maintained | Outperform | $60.00 from $52.00 | Jun 18, 2026 |
| Citigroup | Maintained | Buy | $70.00 from $62.00 | Jun 15, 2026 |
| Wells Fargo | Maintained | Overweight | $65.00 from $50.00 | Jun 12, 2026 |
| Wedbush | Maintained | Outperform | $55.00 | Jun 3, 2026 |
| Citigroup | Maintained | Buy | $62.00 from $59.00 | Jun 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $67.00 from $57.00 | Jun 2, 2026 |
| Wells Fargo | Maintained | Overweight | $50.00 from $40.00 | May 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 from $47.00 | May 5, 2026 |
| Wedbush | Maintained | Outperform | $55.00 from $53.00 | May 5, 2026 |
| Citigroup | Maintained | Buy | $59.00 from $53.00 | May 5, 2026 |
Frequently asked questions
What is the latest analyst rating on TVTX?
On Aug 10, 2026, Evercore ISI Group maintained Travere Therapeutics at Outperform with a price target of $78.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
